A detailed history of Jpmorgan Chase & CO transactions in Retractable Technologies Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 33 shares of RVP stock, worth $22. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 33 -0.0%
Holding current value
$22
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.08 - $1.34 $7 - $9
7 Added 26.92%
33 $0
Q4 2023

Feb 12, 2024

BUY
$0.97 - $1.21 $9 - $12
10 Added 62.5%
26 $0
Q3 2023

Nov 14, 2023

BUY
$1.09 - $1.29 $17 - $20
16 New
16 $0
Q2 2022

Aug 11, 2022

SELL
$3.39 - $4.69 $27,560 - $38,129
-8,130 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$4.3 - $7.26 $38,923 - $65,717
-9,052 Reduced 52.68%
8,130 $39,000
Q4 2021

Feb 10, 2022

BUY
$6.74 - $10.69 $69,988 - $111,004
10,384 Added 152.75%
17,182 $119,000
Q3 2021

Nov 12, 2021

BUY
$10.3 - $13.45 $70,019 - $91,433
6,798 New
6,798 $75,000

Others Institutions Holding RVP

About RETRACTABLE TECHNOLOGIES INC


  • Ticker RVP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 32,937,200
  • Market Cap $22.7M
  • Description
  • Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...
More about RVP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.